1. Home
  2. HIO vs IVA Comparison

HIO vs IVA Comparison

Compare HIO & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HIO
  • IVA
  • Stock Information
  • Founded
  • HIO 1993
  • IVA 2011
  • Country
  • HIO United States
  • IVA France
  • Employees
  • HIO N/A
  • IVA N/A
  • Industry
  • HIO Finance/Investors Services
  • IVA Biotechnology: Pharmaceutical Preparations
  • Sector
  • HIO Finance
  • IVA Health Care
  • Exchange
  • HIO Nasdaq
  • IVA Nasdaq
  • Market Cap
  • HIO 369.0M
  • IVA 359.6M
  • IPO Year
  • HIO N/A
  • IVA 2020
  • Fundamental
  • Price
  • HIO $3.99
  • IVA $3.09
  • Analyst Decision
  • HIO
  • IVA Strong Buy
  • Analyst Count
  • HIO 0
  • IVA 4
  • Target Price
  • HIO N/A
  • IVA $10.50
  • AVG Volume (30 Days)
  • HIO 305.3K
  • IVA 29.4K
  • Earning Date
  • HIO 01-01-0001
  • IVA 03-26-2025
  • Dividend Yield
  • HIO 10.33%
  • IVA N/A
  • EPS Growth
  • HIO N/A
  • IVA N/A
  • EPS
  • HIO N/A
  • IVA N/A
  • Revenue
  • HIO N/A
  • IVA $14,591,573.00
  • Revenue This Year
  • HIO N/A
  • IVA $15.38
  • Revenue Next Year
  • HIO N/A
  • IVA $24.22
  • P/E Ratio
  • HIO N/A
  • IVA N/A
  • Revenue Growth
  • HIO N/A
  • IVA N/A
  • 52 Week Low
  • HIO $3.52
  • IVA $1.53
  • 52 Week High
  • HIO $4.03
  • IVA $4.05
  • Technical
  • Relative Strength Index (RSI)
  • HIO 70.57
  • IVA 41.87
  • Support Level
  • HIO $3.88
  • IVA $3.00
  • Resistance Level
  • HIO $3.94
  • IVA $3.40
  • Average True Range (ATR)
  • HIO 0.03
  • IVA 0.20
  • MACD
  • HIO 0.01
  • IVA -0.04
  • Stochastic Oscillator
  • HIO 100.00
  • IVA 12.28

About HIO Western Asset High Income Opportunity Fund Inc.

Western Asset High Income Oppor Fd Inc is a diversified closed-end management investment company. The company's primary objective is to seek high current income and the secondary objective is capital appreciation. It invests a majority of its net assets in high-yield corporate debt securities and the rest in common stock equivalents, including options, warrants, and rights. The company invests in securities of companies from various sectors such as energy, technology, utilities, industrials, communications, finance, and capital goods among others.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: